Veterinary Medicines

Doxyveto-C 500 mg/g Powder for use in drinking water/milk

Authorised
  • Doxycycline hyclate
Download as PDF

Product identification

Medicine name:
Doxyveto-C 500 mg/g Powder for use in drinking water/milk
Doxyveto-C 500 mg/g Powder for use in drinking water/milk
DOXYCYCLINE VMD 500 MG/G ΚΟΝΙΣ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ/ΓΑΛΑ
Active substance:
  • Doxycycline hyclate
Target species:
  • Cattle (pre-ruminant)
  • Pig
  • Chicken (broiler)
  • Chicken (layer hen)
  • Chicken (pullet future breeder)
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Doxycycline hyclate
    500.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (pre-ruminant)
      • Meat and offal
        7
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        8
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
      • Egg
        no withdrawal period
    • Chicken (layer hen)
      • Egg
        no withdrawal period
      • Meat and offal
        5
        day
    • Chicken (pullet future breeder)
      • Meat and offal
        5
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk 1 kg
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk jar 1 kg
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk jar 100 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 77610/05-07-2024/K-0224601
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0032/001
Concerned member states:
  • Bulgaria
  • Croatia
  • France
  • Greece
  • Hungary
  • Luxembourg
  • Netherlands
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 20/08/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 20/08/2024
Download